RecruitingNot ApplicableNCT05992363

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

Sponsor

Rabin Medical Center

Enrollment

106 participants

Start Date

Dec 20, 2023

Study Type

INTERVENTIONAL

Conditions

Malignancy Hydronephrosis; Obstruction, Ureter Renal Failure Ureter Obstruction Ureter Stricture

Summary

Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of plastic tubes (stents) placed in the ureter (the tube connecting the kidney to the bladder) to keep urine flowing when cancer is blocking it. One uses two smaller polyurethane stents placed together; the other uses a single silicone stent. **You may be eligible if...** - You have a blockage in your ureter caused by cancer - You are able to understand and give consent to participate **You may NOT be eligible if...** - Your ureter is blocked for a reason other than cancer (such as a kidney stone or scar tissue) - You have difficulty understanding the consent process due to language or cognitive barriers Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.